HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Figures Only Full Text (PDF) All Versions of this Article: AJPH.2004.045260v1 96/2/252    most recent Submit a response View responses Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (81) Citing Articles via Google Scholar Google Scholar Articles by Garland, C. F. Articles by Holick, M. F. Search for Related Content PubMed PubMed Citation Articles by Garland, C. F. Articles by Holick, M. F. Related Collections Cancer Epidemiology Genetics Public Health Practice Other Race/Ethnicity

Cedric F. Garland, DrPH, Frank C. Garland, PhD, Edward D. Gorham, PhD, MPH, Martin Lipkin, MD, Harold Newmark, ScD, Sharif B. Mohr, MPH and Michael F. Holick, MD, PhD

Cedric F. Garland, Frank C. Garland, and Edward D. Gorham are with the Department of Family and Preventive Medicine, University of California, San Diego. Cedric F. Garland, Frank C. Garland, Edward D. Gorham, and Sharif B. Mohr are with the Naval Health Research Center, San Diego, Calif. Martin Lipkin is with the Strang Cancer Prevention Center, New York, NY. Harold Newmark is with the Laboratory for Cancer Research, Department of Chemical Biology, Rutgers University, Piscataway, NJ. Michael F. Holick is with the Vitamin D Laboratory, Section of Endocrinology, Nutrition and Diabetes, Department of Medicine, Boston University School of Medicine, Boston, Mass.

Correspondence: Requests for reprints should be sent to Cedric Garland, DrPH, Department of Family and Preventive Medicine, 0631C, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0631 (e-mail: cgarland{at}ucsd.edu).

	ABSTRACT

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 

Vitamin D status differs by latitude and race, with residents of the northeastern United States and individuals with more skin pigmentation being at increased risk of deficiency. A PubMed database search yielded 63 observational studies of vitamin D status in relation to cancer risk, including 30 of colon, 13 of breast, 26 of prostate, and 7 of ovarian cancer, and several that assessed the association of vitamin D receptor genotype with cancer risk.

The majority of studies found a protective relationship between sufficient vitamin D status and lower risk of cancer. The evidence suggests that efforts to improve vitamin D status, for example by vitamin D supplementation, could reduce cancer incidence and mortality at low cost, with few or no adverse effects.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
ALTHOUGH VITAMIN D deficiency is known mainly for its association with fractures and bone disease,^1–7 its newly recognized association with risk of several types of cancer is receiving considerable attention.^8–11 The high prevalence of vitamin D deficiency, combined with the discovery of increased risks of certain types of cancer in those who are deficient, suggest that vitamin D deficiency may account for several thousand premature deaths from colon,¹² breast,^13,14 ovarian,¹⁵ and prostate¹⁶ cancer annually.¹⁷ This discovery creates a new impetus for ensuring adequate vitamin D intake in order to reduce the risk of cancer.

	PREVALENCE OF VITAMIN D DEFICIENCY

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
A low serum level of 25(OH)D, the principal form of circulating vitamin D, is the main marker of vitamin D deficiency.^18–20 High prevalence of vitamin D deficiency is present in all races, even in temperate areas,^19–36 and is particularly high among Black Americans.^19,21–24 A recent survey found, for example, that 42% of Black women had seriously deficient 25(OH)D levels (< 15 ng/mL).¹⁹

Residents of the northern tier of the United States receive considerably less solar ultraviolet B (UVB) radiation than those in the South, owing to the longer length and severity of northern winters.^37–39 UVB is needed to make vitamin D, which cannot be photosynthesized by the skin in the Northeast from November through March.⁴⁰ Although some sunscreens, such as zinc or titanium oxides, may reduce risk of some skin cancers,^41–43 everyday use of sunscreens that offer a high level of protection against the sun, which currently are used periodically by about half the US population,⁴⁴ completely blocks photosynthesis of vitamin D^45,46 and reduces circulating vitamin D metabolites.⁴⁶ This results in 25(OH)D deficiency unless there is adequate oral intake.⁴⁷

A clinical laboratory test is available to identify 25(OH)D deficiency; it is most useful during the fall and winter, when deficiency is prevalent^29,30 owing to the 3-week half-life of 25(OH)D.^18,48 With respect to osteoporosis, the range of 25(OH)D considered deficient is less than 15 to 20 ng/mL,⁴⁹ whereas serum levels below 30 ng/mL are associated with increased risk of colon cancer.^50–52 Levels above 150 ng/mL suggest potential toxicity.^53–55

	EPIDEMIOLOGICAL EVIDENCE

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
Most observational studies have reported that vitamin D has a beneficial effect on risk of colon, breast, prostate, and ovarian cancer. A PubMed search (in December 2004) for epidemiological studies of vitamin D, sunlight, ultraviolet radiation, and latitude in association with these cancers yielded 63 studies, including 30 of colon cancer, 13 of breast cancer, 26 of prostate cancer, and 7 of ovarian cancer (some studies included more than one site).

Of the 30 studies of colon cancer or adenomatous polyps, 20 found a statistically significant benefit of vitamin D, its serum metabolites, sunlight exposure, or another marker of vitamin D status on cancer risk or mortality^{12,13,50–52,56–66} and incidence of adenomatous polyps,^67–70 including 1 study in which the association was limited to men⁶⁵; 5 studies reported a beneficial effect (of borderline statistical significance) of vitamin D or its markers on risk of colon or rectal cancer,^71–75 and 5 reported no association.^76–80

Of the 13 studies of breast cancer, 9 reported a favorable association of vitamin D markers or sunlight with cancer risk,^{13,14,57,64,75,81–84} including 1 where the association was limited to premenopausal women⁸⁴; 1 study reported a favorable trend of borderline statistical significance⁸⁵ and 3 found no association.^66,80,86 None reported adverse effects.

Thirteen of the 26 studies of prostate cancer found a statistically significant favorable association,^{16,17,64,75,87–95} 1 reported a favorable trend for serum 25(OH)D of borderline significance,⁹⁶ and 11 reported no statistically significant association.^{66,80,97–105} One reported a U-shaped association¹⁰⁶ and 1 reported a significant inverse correlation with latitude, with a weaker correlation with UVB.⁹⁴ Five of the 7 studies of ovarian cancer found higher mortality associated with lower regional sunlight^15,17,64,75 or lower vitamin D intake,¹⁰⁷ although 2 reported no association with sunlight.^66,80

The consistency of the findings of dietary and serum studies with those of geographic studies allowed triangulation on vitamin D as a common factor in risk of colon cancer,^{12,13,17,50–52,56–59,61–64} colonic adenomas,^67–70 breast cancer,^{14,17,57,64,75,81,82,84} prostate cancer,^{16,17,64,75,87–95,108,109} and ovarian cancer.^{15,17,64,94,107}

Dietary studies^{56,58,60–63,71–74,76–79,84,100–102,105,107} had certain limitations that contrasted with studies of serum.^{50–52,59,67,68,82,86,88,90,97,98,110} Dietary studies in the United States were somewhat limited because it was difficult to fully separate associations of vitamin D from those of calcium, because both are in milk. There are many foods, however, that contain substantial amounts of vitamin D but little calcium, including fatty ocean fish.^111,112 Higher intake of fatty fish was associated with lower mortality rates of colon^113,114 and breast^114,115 cancer in international comparisons, and of prostate cancer in cohort studies.^116,117

Although serum studies have the advantage of measuring vitamin D status regardless of source, they can be confounded by associations with physical activity, particularly in studies of colon cancer. An association between greater physical activity and lower risk of colon cancer has been reported,^118–120 although this was not always found.¹²¹ A common link could be that physical activity raises serum levels of 1,25(OH)₂D, the most biologically active metabolite of vitamin D.¹²²

Six of 7 prediagnostic serum studies of colon cancer or adenomas reported significantly higher risk of colon cancer^50–52 and adenomas^67–69 in those with low 25(OH)D levels, whereas 1 reported a trend suggestive of higher risk in those with low serum 25(OH)D.⁵⁹ Both studies of the role of vitamin D in breast cancer analyzed 1,25(OH)₂D, rather than 25(OH)D.^82,86 One reported that the risk of breast cancer was markedly higher in women with low prediagnostic 1,25(OH)₂D,⁸² but the other found no association.⁸⁶ Lower levels of 25(OH)D⁹⁰ or 1,25(OH)₂D⁸⁸ were associated with higher risk of prostate cancer in 2 studies, but not in others.^{97,98,103,110} Some of the latter may not have detected an association with 1,25(OH)₂D because its serum concentration is homeostatically regulated.^123,124 On the other hand, some individuals with prolonged poor vitamin D status have below-average levels of 1,25(OH)₂D,^125,126 possibly accounting for the studies that found that individuals with low serum 1,25(OH)₂D had high risk of breast⁸² and prostate⁸⁸ cancer.

Vitamin D synthesis¹²⁷ and serum 25(OH)D levels^128–130 are inversely correlated with latitude and positively correlated with sunlight, consistent with higher incidence or mortality rates for colon^{12,13,17,57,75} and breast cancer,^{13,14,17,57,75,81} especially in areas 37° or more from the equator. There are also north–south gradients for ovarian^15,17,64,75 and prostate^{16,17,64,75,87,92,94} cancer. Some of the gradient for breast cancer may be associated with reproductive factors.^131,132

UVB exposure and vitamin D intake increase serum 25(OH)D levels in a dose-dependent manner^133–135 by providing a higher concentration of 25(OH)D as substrate for synthesis of 1,25(OH)₂D. Normal colon,^136–138 breast,^139,140 and prostate¹⁴¹ epithelial cells have a vitamin D receptor (VDR) that is highly sensitive to 1,25(OH)₂D. This could provide a mechanism of anticarcinogenic action for either circulating or locally synthesized 1,25(OH)₂D.

Because synthesis of circulating 1,25(OH)₂D is regulated in the kidney by parathyroid hormone,¹³³ increased UVB exposure usually does not elevate circulating 1,25(OH)₂D. 1,25(OH)₂D is the most active vitamin D metabolite, although its concentration in serum is one thousandth that of 25(OH)D.¹⁴² It is synthesized from 25(OH)D by 1--hydroxylase enzymes in the colon,¹⁴³ prostate,¹⁴⁴ breast,¹⁴⁵ and other tissues¹⁴⁶ through an autonomous mechanism not homeostatically regulated by parathyroid hormone.

The fact that 1,25(OH)₂D is synthesized in colon epithelium provides a possible explanation for lower incidence rates of colon cancer^50–52 and adenomatous polyps^67–69 in individuals with higher levels of serum 25(OH)D. It also helps explain the association of residence at sunnier latitudes with lower mortality rates from colon,^12,17,56,64 breast,^{13,14,17,64,85} ovary,^15,17,64 and prostate^{16,17,64,87,90,91} cancer, because sunlight increases 25(OH)D levels, thereby providing more substrate for these tissues to make 1,25(OH)₂D.

	RACIAL FACTORS

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
Blacks have levels of 25(OH)D approximately half those of Whites.^{19,20,23,147–150} Blacks in northern cities with large Black populations (Chicago, Minneapolis, Detroit, Buffalo, Cleveland, and Toledo) have colon cancer mortality rates substantially higher than those of Whites.¹⁵¹ Case-fatality rates are higher among Blacks for colon,^152–154 breast,¹⁵⁴ prostate,¹⁵⁴ and ovarian¹⁵⁵ cancer. Colon cancer mortality rates are 33% higher among Blacks, and incidence rates are 19% higher.¹⁵⁶ Breast cancer mortality rates are 28% higher among Blacks, although incidence rates are slightly lower.¹⁵⁶

There is a possibility of confounding by stage at diagnosis, since breast cancer tends to be diagnosed in more advanced stages in Blacks than in Whites.¹⁵⁷ However, differences in stage at diagnosis persisted after adjustment for socioeconomic status.¹⁵⁸ Blacks have substantially poorer survival rates,¹⁵⁹ even when mammographic screening rates are similar to those of Whites.¹⁶⁰ Prostate cancer mortality rates are more than twice as high among Blacks as among Whites, and incidence is 1.6 times higher.^156,159 Ovarian cancer mortality and incidence rates are higher among Whites, although they are rising among Blacks.¹⁵⁶

	GENETIC FACTORS

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
There are several VDR genotypes.¹⁶¹ The most important of these regarding cancer is Bsm I,^162,163 which has 3 variants: BB, Bb, and bb. The bb genotype occurs in 35% of the US population¹⁶⁴ and is associated with lower circulating concentrations of 1,25(OH)₂D.¹⁶² Men with the bb genotype were found to have twice the incidence of colon cancer¹⁶² as those with the BB genotype. In men below the median serum 25(OH)D level, those with the bb genotype had more than twice the incidence of prostate cancer as other men.^162,165 Risk of breast cancer in women with the bb genotype was twice that of women with the BB genotype,^166,167 although breast cancer findings have been mixed.¹⁶⁸ Women with the bb genotype were 4 times more likely to develop metastases than those with the BB genotype.¹⁶⁹ Approximately 40% of colon and prostate cancer may be related to the bb genotype, interacting adversely with low 25(OH)D.¹⁶²

VDR polymorphisms also are associated with a more severe form of malignancy. Men with the VDR Taq I TT genotype, for example, were found to be 5 times more likely to develop a severe (Gleason grade 5) prostate malignancy than those with other genotypes.¹⁷⁰ This differs from previous inconclusive studies of associations of VDR genotypes with prostate cancer.^171,172 Breast cancer cases with the TT genotype were twice as likely to have lymphatic metastases.¹⁷³ The population prevalence of the TT genotype is 35%.¹⁷⁴

These studies have helped define the role of vitamin D in cancer,^{162,163,165,167} although most were exploratory, and only a few of the known VDR genotypes have been shown to be associated with risk of cancer.

	VITAMIN D AND COLON CANCER

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
Age-adjusted death rates for colon cancer tend to be high in areas with low levels of winter sunlight and low in sunny areas (Figure 1; the contour lines show the annual mean daily solar irradiance, measured in Langleys [calories/cm²]).

View larger version (60K): [in this window] [in a new window]   FIGURE 1— Age-adjusted colon cancer mortality rates, by county area, and contours of annual mean daily solar irradiance in Langleys (calories/cm2), United States, 1970–1994. Source. Developed through use of National Cancer Institute and National Oceanic and Atmospheric Administration data (available at http://www3.cancer.gov/atlasplus/charts.html and http://www.noaa.gov).

Seven epidemiological studies reported higher risk of colon cancer in individuals who consumed lower amounts of vitamin D, including the Western Electric Cohort Study,⁵⁶ the Nurses’ Health Study,⁶⁰ the Male Health Professionals’ Follow-Up Study,⁶² the Iowa Women’s Health Study,⁷¹ and the American Cancer Society Cancer Prevention Study II (CPS II) Cohort Study,⁶⁵ and 2 case–control studies.^63,73 The association in the CPS-II Cohort was limited to men.

One study reported a trend toward higher risk of colon cancer with lower vitamin D intake,⁷¹ and another reported an inverse association of vitamin D and calcium intake with risk of rectal cancer.⁷² Another found that lower vitamin D intake was associated with higher risk of adenomas.⁷⁰ The findings of one study of colon cancer were no longer statistically significant after multivariate analysis.⁷¹ Five studies found no association.^76–79,178 Two of these were performed in sunny climates,^76,178 where they could have been influenced by solar vitamin D synthesis. Although the latitude gradient helps to isolate the role of vitamin D, confounding is still possible.

	VITAMIN D AND BREAST CANCER

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
Breast cancer death rates tended to be higher in areas with low winter sunlight levels and lower in sunny areas (Figure 2).^13,14 Women regularly exposed to sunlight, and consumers of above-average amounts of vitamin D, had significantly lower incidence rates of breast cancer.⁸⁵ Women in the lowest quartile of serum 1,25(OH)₂D had a risk of breast cancer 5 times higher than those in the highest quartile.⁸² Low 1,25(OH)₂D levels were also associated with faster progression of metastatic breast cancer.¹⁷⁹ Mortality rates of perimenopausal ovarian cancer also were lower in sunny regions,^15,17,64,75 although one study found no geographic association within a single country.⁸⁰ High intake of vitamin D and calcium markedly reduced incidence of mammary cancer in mice and rats consuming high-fat diets.^9,180 Incidence of mammary cancer was only one quarter as high in rats that received high levels of vitamin D and calcium.¹⁸¹

View larger version (60K): [in this window] [in a new window]   FIGURE 2— Age-adjusted breast cancer mortality rates, by county area, and contours of annual mean daily solar irradiance in Langleys (calories/cm2), United States, 1970–1994. Source. Developed through use of National Cancer Institute and National Oceanic and Atmospheric Administration data (available at http://www3.cancer.gov/atlasplus/charts.html and http://www.noaa.gov).

	VITAMIN D AND PROSTATE CANCER

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

	MECHANISM OF VITAMIN D EFFECTS

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
Vitamin D and its metabolites reduce the incidence of many types of cancer by inhibiting tumor angiogenesis,^182–185 stimulating mutual adherence of cells,¹⁸⁶ and enhancing intercellular communication through gap junctions,¹⁸⁷ thereby strengthening the inhibition of proliferation that results from tight physical contact with adjacent cells within a tissue (contact inhibition). Vitamin D metabolites help maintain a normal calcium gradient in the colon epithelial crypts,¹⁸⁸ and high serum levels of 25(OH)D are associated with markedly decreased proliferation of noncancerous but high-risk epithelial calls in the colon.¹⁸⁹ 1,25(OH)₂D inhibits mitosis of breast epithelial cells.¹⁹⁰ Pulsatile release of ion-ized calcium from intracellular stores, including the endoplasmic reticulum, induces terminal differentiation and apoptosis,¹⁷⁶ and 1,25(OH)₂D enhances this release.¹⁹¹

	RECOMMENDATIONS FOR VITAMIN D INTAKE

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
The National Academy of Sciences recommends the following daily intakes of vitamin D: 1 to 50 years of age, 200 international units (IU); 51 to 70 years, 400 IU; older than 71 years, 600 IU.¹⁹² In one study, 500 IU per day was associated with a 25(OH)D level of 30 ng/mL, although this included photosynthesized vitamin D.¹⁹³ Sufficient vitamin D intake to achieve 30 to 35 ng/mL of 25(OH)D in serum was associated with reduced incidence of colonic adenomas,^67,69 the latter in combination with adequate calcium intake. On the basis of the studies of serum 25(OH)D and risk of colorectal cancer cited in this article, the target range for serum 25(OH)D should be at least 30 ng/mL, but no more than 150 ng/mL.^149,194 The National Academy of Sciences does not recommend a different intake of vitamin D by Blacks, although it suggests a need for further research on racial differences.¹⁹² On the basis of the markedly higher prevalence of 25(OH)D deficiency in Blacks,^19,147 a higher level of supplementation is probably needed. Althought adverse VDR genotypes^{162,165–167,169} are present in a large proportion of the population,^164,174 different intakes according to genotype would not be practical.

Older adults need higher amounts of vitamin D owing to decreased absorption,¹⁹⁵ and at any age, serum 25(OH)D rises as an inverse power function of vitamin D intake.¹⁹⁶ Intake of 800 (IU) of vitamin D₃ per day, for example, would increase serum 25(OH)D by only 6 ng/mL,¹⁹³ so there is no reasonable concern about inducing toxicity with daily intake of 800 to 1000 IU per day.¹⁹⁷ The latter intake would be consistent with maintaining the serum 25(OH)D level at or above 30 ng/mL in most individuals.^69,198 New vitamin D analogs have promising cellular effects, but are not currently used for prevention.¹⁹⁹

Throughout the United States, the estimated daily solar exposure to maintain a serum 25(OH)D level of 30 ng/mL is 15 minutes in summer and 20 minutes in early fall or late spring, from 11:00 AM to 2:00 PM under clear skies,^18,40,200 assuming exposure of arms, shoulders, and back. Blacks require twice as long.¹⁴⁷ During November to March, north of 37° latitude in the Northeastern and mid-Atlantic regions, no amount of solar exposure is sufficient,⁴⁰ partly owing to a slightly thicker regional stratospheric ozone layer²⁰¹ and denser tropospheric sulfate aerosol.^202,203 In the Northwest and most other regions, some UVB is available during winter, although low ambient temperatures limit duration and area of exposure.^{37,38,40,127,147,200}

Moderation is needed concerning sunlight exposure. Actinic changes are associated with exposure to ultraviolet radiation, and there is considerable evidence for its role in skin cancer.^42,43 If sunlight is used as a source of vitamin D, exposure should be scrupulously monitored so that no reddening of the skin occurs,^200,204 and intentional exposure of the face should be minimized. Individuals with skin type I or II, who tend to burn easily and tan poorly,²⁰⁵ should not exceed 20 minutes per day in the sun. Exposure times much longer than 20 minutes would not appreciably increase vitamin D synthesis and could increase risk of skin cancer.²⁰⁶ Oral vitamin D₃ supplementation, rather than solar exposure, should be used by fair-skinned or sun-sensitive persons, or by individuals taking medicines causing photosensitivity.

	POTENTIAL TOXICITY

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
Vitamin D dosages of up to 1000 IU per day have no reasonable likelihood of producing toxicity. Serum 25(OH)D levels of at least 30 ng/mL²⁰⁷ to 45 ng/mL^143,208 are the minimum necessary to maintain normal parathyroid hormone levels, and at least 400 IU of supplemental vitamin D₃ per day is needed to maintain serum 25(OH)D at a range consistent with normal parathyroid hormone levels in young and middle-aged adults; intake of at least 600 IU per day is required to maintain normal levels in adults aged older than 70 years.¹⁹² The National Academy of Sciences–Institute of Medicine has indicated that 2000 IU per day is the safe upper limit of vitamin D intake.¹⁹² Typical recommended intakes are far below this.^192,209

Potential toxic effects of vitamin D overdosage, such as bone demineralization, hypercalcemia, hypercalciuria, or nephrocalcinosis with renal failure, are encountered rarely, generally only when the daily dose exceeds 10 000 IU of vitamin D on a chronic basis.⁵⁵ Concerns about vitamin D toxicity in the past have been because of massive overdoses in the range of 50 000 to 150 000 IU per day on a long-term basis.^54,133 According to the National Academy of Sciences, no known health risks are associated with dosages of vitamin D in the normally encountered range of intake (up to 2000 IU/day).^{55,192,197,198,210,211}

Relatively high oral intakes of vitamin D or serum levels of 25(OH)D are not a concern from a cardiovascular viewpoint, because most studies suggest that higher levels of 25(OH)D are associated with reduced cardiovascular risk. For example, higher serum 25(OH)D,²¹² 1,25(OH)₂D,^213,214 and oral vitamin D²¹⁵ were associated with moderately but significantly lower blood pressure.

There also was a beneficial association between serum 25(OH)D and risk of myocardial infarction,²¹⁶ ischemic heart disease mortality,²¹⁷ and congestive heart failure,²¹⁸ although other cardiovascular results have been mixed.^219,220

Vitamin D supplementation was also associated with reduced incidence of type I diabetes^221,222 and with improvement in type II diabetes.^223,224 In Finland, vitamin D supplementation of infants was associated with reduction by four fifths in incidence of type I diabetes.²²¹ Higher regional UVB levels have also been linked with lower age-adjusted death rates from endometrial and kidney cancers, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, multiple myeloma, and other malignancies.⁷⁵

	ADOPTION OF VITAMIN D FOR CANCER PREVENTION

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
Supplemental vitamin D intake could address the high prevalence of vitamin D deficiency in the United States.^1,55,198,225 Strong evidence indicates that intake or synthesis of vitamin D is associated with reduced incidence and death rates of colon, breast, prostate, and ovarian cancers. More than 1000 laboratory and epidemiological studies have been published concerning the association between vitamin D and its metabolites and cancer. Long-term studies have demonstrated the efficacy of moderate intake of vitamin D in reducing cancer risk and, when administered with calcium, in reducing the incidence of fractures.²²⁶ Despite these reassuring studies, the public health and medical communities have not adopted use of vitamin D for cancer prevention.

The cost of a daily dose of vitamin D₃ (1000 IU) is less than 5 cents, which could be balanced against the high human and economic costs of treating cancer attributable to insufficiency of vitamin D. Leadership from the public health community will provide the best hope for action.

	Acknowledgments

 
This research was supported by a congressional allocation to the Hollings Cancer Center of the Medical University of South Carolina, Charleston, through the Department of the Navy, Bureau of Medicine and Surgery (Work Unit No. 60126 TR 03–1)7.

The authors thank William B. Grant of SUNARC, San Francisco, Calif, for reviewing the article and providing comments.

Note. The views expressed in this report are those of the authors and do not represent an official position of the Department of the Navy, Department of Defense, or the US Government.

	Footnotes

 
Peer Reviewed

Contributors
C. F. Garland, F. C. Garland, and E. D. Gorham jointly developed the plan and outline of the article, prepared the first draft, and reviewed and edited subsequent drafts. S.B. Mohr and C.F. Garland jointly performed the literature review, and S. B. Mohr edited drafts of the article. M. Lipkin, H. Newmark, and M. F. Holick reviewed and edited drafts.

Accepted for publication January 18, 2005.

	References

TOP ABSTRACT INTRODUCTION PREVALENCE OF VITAMIN D... EPIDEMIOLOGICAL EVIDENCE RACIAL FACTORS GENETIC FACTORS VITAMIN D AND COLON... VITAMIN D AND BREAST... VITAMIN D AND PROSTATE... MECHANISM OF VITAMIN D... RECOMMENDATIONS FOR VITAMIN D... POTENTIAL TOXICITY ADOPTION OF VITAMIN D... References

 
1. Utiger R. The need for more vitamin D. N Engl J Med. 1998;338(12): 828–829.[Free Full Text]

2. Holick MF. Too little vitamin D in premenopausal women: why should we care? Am J Clin Nutr. 2002;76(1):3–4.[Free Full Text]

3. Compston J. Vitamin D deficiency: time for action. Evidence supports routine supplementation for elderly people and others at risk. BMJ. 1998;317(7171): 1466–1467.[Free Full Text]

4. Wharton B. Low plasma vitamin D in Asian toddlers in Britain. BMJ. 1999; 318(7175):2–3.[Free Full Text]

5. Garabedian M, Ben-Mehkbi H. Rickets and vitamin D deficiency. In: Holick M, ed. Vitamin D: Molecular Biology, Physiology, and Clinical Applications. Totowa, NJ: Humana; 1999: 273–286.

6. Holick M. Vitamin D and bone health. J Nutr. 1996;126(4 suppl): 1159S–1164S.[Abstract/Free Full Text]

7. McCollum E, Simmonds N, Becker J, Shipley P. Studies on experimental rickets, XXI: an experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem. 1922;53:293–312.[Free Full Text]

8. Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 1997;6(9):727–732.[Abstract]

9. Lipkin M, Newmark HL. Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr. 1999;18 (5 suppl):392S–397S.[Abstract/Free Full Text]

10. Guyton KZ, Kensler TW, Posner GH. Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu Rev Pharmacol Toxicol. 2001;41: 421–442.[Medline]

11. Hansen CM, Binderup L, Hamberg KJ, Carlberg C. Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci. 2001;6:D820–D848.[ISI][Medline]

12. Garland C, Garland F. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980;9: 227–231.[Abstract/Free Full Text]

13. Gorham E, Garland C, Garland F. Acid haze air pollution and breast and colon cancer in 20 Canadian cities. Can J Public Health. 1989;80:96–100.[ISI][Medline]

14. Garland F, Garland C, Gorham E, Young J Jr. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990;19: 614–622.[CrossRef][ISI][Medline]

15. Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol. 1994;23(6):1133–1136.[Abstract/Free Full Text]

16. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res. 1990;10(5A):1307–1311.[ISI][Medline]

17. Grant WB. An estimate of premature cancer mortality in the US because of inadequate doses of solar ultraviolet-B radiation. Cancer. 2002;94(6): 1867–1875.[CrossRef][ISI][Medline]

18. Holick M. The use and interpretation of assays for vitamin D and its metabolites. J Nutr. 1990;120: 1464–1469.[Abstract/Free Full Text]

19. Nesby-O’Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2002; 76(1):187–192.[Abstract/Free Full Text]

20. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30(5):771–777.[Medline]

21. Awamey E, Hollis B, Bell N. Low serum 25-hydroxyvitamin D in blacks results from decreased production rate and not increased metabolic clearance rate [abstract]. J Bone Miner Res. 1996; 11:S165.

22. Mitra D, Bell N. Racial, geographic, genetic and body habitus effects on vitamin D metabolism. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. San Diego, Calif: Academic Press; 1997: 521–532.

23. Aloia JF, Mikhail M, Pagan CD, Arunachalam A, Yeh JK, Flaster E. Biochemical and hormonal variables in black and white women matched for age and weight. J Lab Clin Med. 1998; 132(5):383–389.[CrossRef][ISI][Medline]

24. Kyriakidou-Himonas M, Aloia JF, Yeh JK. Vitamin D supplementation in postmenopausal black women. J Clin Endocrinol Metab. 1999;84(11): 3988–3990.[Abstract/Free Full Text]

25. Agarwal KS, Mughal MZ, Upadhyay P, Berry JL, Mawer EB, Puliyel JM. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India. Arch Dis Child. 2002; 87(2):111–113.[Abstract/Free Full Text]

26. Guillemant J, Le HT, Maria A, Allemandou A, Peres G, Guillemant S. Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements. Osteoporos Int. 2001; 12(10):875–879.[CrossRef][ISI][Medline]

27. Juttmann J, Visser T, Buurman C. Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. Br Med J. 1981;282: 1349–1352.[Medline]

28. Nakamura K, Nashimoto M, Matsuyama S, Yamamoto M. Low serum concentrations of 25-hydroxyvitamin D in young adult Japanese women: a cross sectional study. Nutrition. 2001; 17(11–12):921–925.[CrossRef][ISI][Medline]

29. Carnevale V, Modoni S, Pileri M, et al. Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int. 2001;12(12): 1026–1030.[CrossRef][ISI][Medline]

30. Vieth R, Cole DE, Hawker GA, Trang HM, Rubin LA. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr. 2001;55(12):1091–1097.[CrossRef][ISI][Medline]

31. Rucker D, Allan JA, Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ. 2002;166(12):1517–1524.[Abstract/Free Full Text]

32. Kudlacek S, Schneider B, Peterlik M, et al. Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest. 2003;33(4):323–331.[CrossRef][ISI][Medline]

33. Rosen CJ, Morrison A, Zhou H, et al. Elderly women in northern New England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone Miner. 1994;25(2): 83–92.[ISI][Medline]

34. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–693.[Abstract/Free Full Text]

35. Dawodu A, Agarwal M, Hossain M, Kochiyil J, Zayed R. Hypovitaminosis D and vitamin D deficiency in exclusively breast-feeding infants and their mothers in summer: a justification for vitamin D supplementation of breast-feeding infants. J Pediatr. 2003;142(2):169–173.[CrossRef][ISI][Medline]

36. Arya V, Bhambri R, Godbole MM, Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int. 2004;15(1):56–61.[CrossRef][ISI][Medline]

37. Frederick J, Lubin D. The budget of biologically active ultraviolet radiation in the earth-atmosphere system. J Geophys Res. 1988;93:3825–3832.

38. Lubin D, Jensen E, Gies P. Global surface ultraviolet radiation climatology from TOMS and ERBE data. J Geophys Res. 1998;103(D20):26061–26091.[CrossRef]

39. Ainsleigh HG. Beneficial effects of sun exposure on cancer mortality. Prev Med. 1993;22(1):132–140.[CrossRef][ISI][Medline]

40. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67(2):373–378.[Abstract]

41. Garland C, Garland F, Gorham E. Could sunscreens increase melanoma risk? Am J Public Health. 1992;82: 614–615.[Free Full Text]

42. Garland C, Garland F, Gorham E. Lack of efficacy of common sunscreens in melanoma prevention. In: Grob J, Stern R, MacKie R, Weinstock M, eds. Epidemiology, Causes and Prevention of Skin Disease. Oxford, England: Black-well Science; 1997:151–159.

43. Manson J, Rexrode K, Garland F, Garland C, Weinstock M. The case of a comprehensive national campaign to prevent melanoma and associated mortality. Epidemiology. 2000;11: 728–734.[CrossRef][ISI][Medline]

44. Johnson EY, Lookingbill DP. Sunscreen use and sun exposure. Trends in a white population. Arch Dermatol. 1984;120(6):727–731.[Abstract]

45. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987;64(6): 1165–1168.[Abstract]

46. Matsuoka LY, Wortsman J, Hollis BW. Use of topical sunscreen for the evaluation of regional synthesis of vitamin D3. J Am Acad Dermatol. 1990; 22(5 Pt 1):772–775.[ISI][Medline]

47. Matsuoka L, Wortsman J, Holick M. Chronic sunscreen use decreases the concentration of 25-hydroxyvitamin D: a preliminary study. Arch Dermatol. 1988;124:1802–1804.[Abstract]

48. Haddad JG Jr, Rojanasathit S. Acute administration of 25-hydroxycholecalciferol in man. J Clin Endocrinol Metab. 1976;42(2):284–290.[Abstract]

49. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly. Endocrinol Rev Monogr. 2000; 22:477–501.

50. Garland C, Comstock G, Garland F, Helsing K, Shaw E, Gorham E. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;2:1176–1178.[ISI][Medline]

51. Tangrea J, Helzlsouer K, Pietinen P, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control. 1997;8(4): 615–625.[CrossRef][ISI][Medline]

52. Feskanich D, Ma J, Fuchs CS, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13(9): 1502–1508.[Abstract/Free Full Text]

53. Holick MF, Shao Q, Liu WW, Chen TC. The vitamin D content